US Stock MarketDetailed Quotes
ENTA Enanta Pharmaceuticals
- 9.210
- +0.130+1.43%
Trading Nov 21 14:58 ET
195.14MMarket Cap-1689P/E (TTM)
9.420High8.750Low183.97KVolume9.000Open9.080Pre Close1.66MTurnover1.13%Turnover RatioLossP/E (Static)21.19MShares17.80052wk High1.31P/B149.88MFloat Cap8.51052wk Low--Dividend TTM16.27MShs Float127.770Historical High--Div YieldTTM7.38%Amplitude8.080Historical Low9.002Avg Price1Lot Size
Enanta Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -40.48%230.09M | 42.95%300.31M | 57.20%337.15M | 48.42%369.91M | 48.42%369.91M | 52.63%386.59M | -25.06%210.08M | -17.21%214.47M | 2.14%249.23M | 2.14%249.23M |
| -Cash and cash equivalents | -62.41%35.78M | -13.17%63.54M | -5.42%39.93M | 94.09%85.39M | 94.09%85.39M | 235.52%95.18M | 78.53%73.18M | -57.38%42.22M | -23.10%43.99M | -23.10%43.99M |
| -Short-term investments | -33.32%194.31M | 72.94%236.77M | 72.55%297.22M | 38.63%284.52M | 38.63%284.52M | 29.56%291.41M | -42.80%136.91M | 7.67%172.25M | 9.87%205.24M | 9.87%205.24M |
| Receivables | -9.32%40.63M | -14.56%39.79M | -22.19%39.91M | -19.21%39.62M | -19.21%39.62M | -7.05%44.81M | -1.89%46.57M | -9.06%51.29M | -19.39%49.04M | -19.39%49.04M |
| -Accounts receivable | -56.72%8.18M | -56.41%7.76M | -63.81%8.17M | -57.60%8.61M | -57.60%8.61M | -3.01%18.89M | -4.92%17.8M | -18.31%22.59M | -13.82%20.32M | -13.82%20.32M |
| -Taxes receivable | 25.23%32.46M | 11.32%32.03M | 10.56%31.73M | 7.96%31M | 7.96%31M | -9.78%25.92M | 0.09%28.77M | -0.17%28.7M | -22.92%28.72M | -22.92%28.72M |
| Restricted cash | --608K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -10.61%15.26M | -24.52%10.93M | -26.20%13.25M | -1.35%13.26M | -1.35%13.26M | 47.93%17.07M | 2.88%14.48M | 55.97%17.95M | -5.24%13.45M | -5.24%13.45M |
| Total current assets | -36.10%286.58M | 29.47%351.03M | 37.57%390.3M | 35.63%422.79M | 35.63%422.79M | 43.26%448.47M | -20.69%271.14M | -13.23%283.7M | -2.29%311.71M | -2.29%311.71M |
| Non current assets | ||||||||||
| Net PPE | 84.15%66.26M | 63.95%58.37M | 3.85%33.46M | 16.69%34.71M | 16.69%34.71M | 28.14%35.98M | 61.61%35.6M | 32.77%32.22M | 179.22%29.75M | 179.22%29.75M |
| -Gross PPE | 154.22%91.47M | 63.95%58.37M | 3.85%33.46M | 13.28%58.46M | 13.28%58.46M | 28.14%35.98M | 61.61%35.6M | 32.77%32.22M | 74.46%51.61M | 74.46%51.61M |
| -Accumulated depreciation | ---25.21M | ---- | ---- | -8.63%-23.75M | -8.63%-23.75M | ---- | ---- | ---- | -15.49%-21.86M | -15.49%-21.86M |
| Investments and advances | 617.59%42.51M | ---- | ---- | --0 | --0 | -84.97%5.92M | -64.38%15.04M | -69.62%26.94M | -72.99%29.29M | -72.99%29.29M |
| Other non current assets | -27.78%3.47M | -10.91%4.16M | 1.37%4.73M | 2.29%4.77M | 2.29%4.77M | 2.72%4.8M | 566.29%4.66M | 567.00%4.67M | 566.29%4.66M | 566.29%4.66M |
| Total non current assets | 140.32%112.24M | 13.05%62.53M | -40.16%38.2M | -38.01%39.48M | -38.01%39.48M | -35.29%46.7M | -14.84%55.31M | -43.83%63.83M | -46.82%63.7M | -46.82%63.7M |
| Total assets | -19.46%398.82M | 26.69%413.56M | 23.30%428.5M | 23.14%462.28M | 23.14%462.28M | 28.54%495.17M | -19.76%326.45M | -21.12%347.53M | -14.44%375.41M | -14.44%375.41M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 34.58%10.68M | -42.81%6.73M | 114.29%9.33M | -31.72%4.1M | -31.72%4.1M | 537.11%7.93M | 96.51%11.76M | -44.50%4.35M | -37.11%6M | -37.11%6M |
| -accounts payable | 34.58%10.68M | -42.81%6.73M | 114.29%9.33M | -31.72%4.1M | -31.72%4.1M | 537.11%7.93M | 96.51%11.76M | -44.50%4.35M | -37.11%6M | -37.11%6M |
| Current accrued expenses | -29.49%12.83M | -31.34%10.63M | -23.48%11.6M | -12.40%18.34M | -12.40%18.34M | -5.18%18.2M | -28.79%15.48M | -42.95%15.16M | -6.66%20.94M | -6.66%20.94M |
| Current debt and capital lease obligation | -54.71%2.43M | -27.26%3.58M | 42.46%4.97M | 82.46%5.28M | 82.46%5.28M | 106.54%5.37M | 63.39%4.92M | 0.49%3.49M | -31.22%2.89M | -31.22%2.89M |
| -Current capital lease obligation | -54.71%2.43M | -27.26%3.58M | 42.46%4.97M | 82.46%5.28M | 82.46%5.28M | 106.54%5.37M | 63.39%4.92M | 0.49%3.49M | -31.22%2.89M | -31.22%2.89M |
| Other current liabilities | -11.99%32.3M | --33.67M | --36.51M | --35.08M | --35.08M | --36.69M | ---- | ---- | ---- | ---- |
| Current liabilities | -14.60%58.23M | 69.77%54.61M | 171.32%62.41M | 110.50%62.79M | 110.50%62.79M | 196.02%68.19M | 4.65%32.17M | -39.30%23M | -17.54%29.83M | -17.54%29.83M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 115.54%48.14M | 88.15%43.41M | -6.11%20.52M | -5.07%21.24M | -5.07%21.24M | 0.56%22.33M | 52.65%23.07M | 36.98%21.86M | 1,886.86%22.37M | 1,886.86%22.37M |
| -Long term capital lease obligation | 115.54%48.14M | 88.15%43.41M | -6.11%20.52M | -5.07%21.24M | -5.07%21.24M | 0.56%22.33M | 52.65%23.07M | 36.98%21.86M | 1,886.86%22.37M | 1,886.86%22.37M |
| Preferred securities outside stock equity | 0.00%1.42M | 0.00%1.42M | 0.00%1.42M | 0.00%1.42M | 0.00%1.42M | -5.51%1.42M | -5.51%1.42M | -5.51%1.42M | -5.51%1.42M | -5.51%1.42M |
| Other non current liabilities | -14.08%142.12M | 36,174.51%148M | 36,678.02%152.26M | 35,162.56%160.09M | 35,162.56%160.09M | 190,020.69%165.41M | -23.02%408K | -20.38%414K | -18.64%454K | -18.64%454K |
| Total non current liabilities | 1.33%191.68M | 674.31%192.84M | 635.18%174.21M | 653.65%182.75M | 653.65%182.75M | 683.08%189.16M | 42.33%24.9M | 29.34%23.7M | 660.16%24.25M | 660.16%24.25M |
| Total liabilities | -2.89%249.91M | 333.58%247.44M | 406.70%236.62M | 354.06%245.54M | 354.06%245.54M | 445.34%257.35M | 18.32%57.07M | -16.92%46.7M | 37.38%54.08M | 37.38%54.08M |
| Shareholders'equity | ||||||||||
| Share capital | 0.95%212K | 0.95%212K | 1.44%212K | 1.44%211K | 1.44%211K | 1.45%210K | 1.94%210K | 1.95%209K | 2.97%208K | 2.97%208K |
| -common stock | 0.95%212K | 0.95%212K | 1.44%212K | 1.44%211K | 1.44%211K | 1.45%210K | 1.94%210K | 1.95%209K | 2.97%208K | 2.97%208K |
| Retained earnings | -64.47%-294.22M | -94.22%-271.56M | -135.31%-240.4M | -182.86%-207M | -182.86%-207M | -281.99%-178.89M | -824.08%-139.82M | -653.41%-102.17M | -250.65%-73.18M | -250.65%-73.18M |
| Paid-in capital | 6.12%443.57M | 6.65%438.13M | 6.69%432.61M | 6.70%424.69M | 6.70%424.69M | 7.66%418M | 9.10%410.8M | 10.56%405.47M | 13.39%398.03M | 13.39%398.03M |
| Gains losses not affecting retained earnings | 56.58%-653K | 63.25%-667K | 80.04%-534K | 68.47%-1.17M | 68.47%-1.17M | 58.45%-1.5M | 40.24%-1.82M | -165.90%-2.68M | -874.87%-3.72M | -874.87%-3.72M |
| Total stockholders'equity | -37.38%148.92M | -38.33%166.11M | -36.22%191.88M | -32.55%216.74M | -32.55%216.74M | -29.64%237.82M | -24.88%269.38M | -21.74%300.84M | -19.55%321.33M | -19.55%321.33M |
| Total equity | -37.38%148.92M | -38.33%166.11M | -36.22%191.88M | -32.55%216.74M | -32.55%216.74M | -29.64%237.82M | -24.88%269.38M | -21.74%300.84M | -19.55%321.33M | -19.55%321.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data